Introduction

ETM

Experimental and Therapeutic Medicine

1792-0981 1792-1015

D.A. Spandidos

ETM-23-4-11243

10.3892/etm.2022.11243

Articles

Vitamin D receptor deficiency increases systolic blood pressure by upregulating the renin-angiotensin system and autophagy

Jia

Jian

1 Tao

2 Tian

Zhouning

3 Liu

Jing

4 Ye

Xiaoman

2 Zhan

Yiyang

1Department of General Practice, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China 2Department of Geriatric Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China 3Department of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China 4The First School of Clinical Medicine, Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China

Correspondence to: Dr Yiyang Zhan, Department of Geriatric Medicine, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu 210029, P.R. China yiyangzhan@sina.com

04 2022

01 03 2022

23 4

314

02 06 2021 30 11 2021

2020

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

The vitamin D receptor (VDR) may regulate blood pressure via multiple pathways. The present study investigated the underlying mechanism by which VDR deficiency increases blood pressure. A total of 16 8-week-old male littermate mice were randomly divided into the VDR knockout and wild-type groups (VDR^-/- and VDR^+/+, respectively). Blood pressure was measured using a four-channel PowerLab data acquisition and ADI software analysis system. After euthanasia, vascular smooth muscle cells (VSMCs) were isolated from the VDR^-/- and VDR^+/+ mice. Oxidative stress, renin-angiotensin system (RAS) activation and autophagy markers were measured in the isolated VSMCs using reverse transcription-quantitative PCR (RT-qPCR), western blotting and transmission electron microscopy (TEM) assays. Mean systolic pressure was significantly higher in the VDR^-/- mice compared with the VDR^+/+ mice. RT-qPCR and western blotting analyses indicated that RAS markers (angiotensin II and II type 1 receptor) were significantly upregulated, oxidative stress was increased (evidenced by reduced superoxide dismutase and peroxiredoxin-4) and autophagy was activated (upregulation of autophagy related protein 7, Beclin 1 and microtubule-associated proteins 1A/1B light chain 3A) in the VDR^-/- VSMCs compared with the VDR^+/+ VSMCs. TEM demonstrated that there were more autophagy bodies in the VDR^-/- VSMCs compared with the VDR^+/+ VSMCs. In conclusion, VDR deficiency was associated with high blood pressure. The mechanism underlying the increase in blood pressure caused by VDR deficiency may involve activation of the RAS, as well as increased oxidative stress and autophagy of VSMCs.

vitamin D receptor hypertension vascular smooth muscle cell oxidative stress autophagy

Funding: This study was supported by Young Scholars Fostering fund of the First Affiliated Hospital of Nanjing Medical University (PY2021015); Jiangsu Province ‘Six Talent Peaks’ High-Level Talent Project (grant no. WSN-024); and Jiangsu Research Center for Primary Health Development and General Practice Education (grant no. 2019B03).

Introduction

Vitamin D signaling plays a role in regulating blood pressure through influencing vascular endothelial function, oxidative stress and activation of the renin-angiotensin-system (RAS), as well as increasing insulin resistance. The widespread effect of vitamin D relies on the extensive presence of the vitamin D receptor (VDR), which is expressed in every human tissue and nearly all nucleated cells, although at varying levels. It is currently hypothesized that almost all biological actions of vitamin D are mediated by its active form, 1,25(OH)₂D, signaling mainly through the intracellular VDR (1). Vitamin D signaling has been associated with elevated plasma renin and angiotensin (Ang) II levels (2). Animal experiments have indicated that 1,25(OH)₂D₃ can inhibit renin gene transcription (3), and Zhou et al (4) revealed that blood pressure is higher in 1α(OH)ase^-/- mice compared with wild-type mice, which is accompanied by elevated mRNA expression levels of renin, plasma aldosterone and Ang II. These studies indicate that 1,25(OH)₂D₃ may influence blood pressure by regulating the central and peripheral RAS through an anti-oxidative stress mechanism. Another in vivo experiment (5) suggested that vitamin D deficiency increases Ang II and oxygen anion levels in local vascular smooth muscle cells (VSMCs). Several studies have also demonstrated that 1,25(OH)₂D₃ deficiency can increase blood pressure by inducing oxidative stress pathways and over-activating the central RAS (6-8).

When vitamin D levels are adequate, a number of the intracellular oxidative stress-related activities are downregulated. Suboptimal concentrations of serum 25(OH)D fail to subdue oxidative stress conditions, augment intracellular oxidative damage and decrease the rate of apoptosis. Superoxide dismutase (SOD) belongs to a group of antioxidant enzymes that play a significant role in regulating oxidative stress in cells (9). Peroxiredoxin 4(Prdx4), a typical endoplasmic reticulum-resident 2-Cys antioxidant of peroxiredoxins, can fine-tune hydrogen peroxide catabolism, which affects cell survival by affecting redox balance, oxidative protein folding and hydrogen peroxide signaling (10). Vitamin D can regulate autophagy at different levels, including induction, nucleation and elongation to maturation and degradation, which affects the occurrence and development of diseases (11).

We previously investigated the association between VDR gene polymorphisms and hypertension. We revealed polymorphisms in VDRrs11574129, rs2228570 and rs739837 in 2,409 patients with hypertension and 3,063 controls, and that the rs2228570 polymorphism is significantly correlated with risk of hypertension (12). However, the mechanism by which vitamin D signaling regulates blood pressure remains unclear. Therefore, the present study established a VDR deficiency animal model using VDR knockout mice to investigate how VDR regulates blood pressure.

Materials and methods <sec> <title>Animals

VDR^-/- mice were derived by homologous recombination in embryonal stem cells as described previously (gifted from Dr Marie Demay; Massachusetts General Hospital, MA, USA) (13). VDR wild-type (VDR^+/+) and knockout (VDR^-/-) mice were identified using western blotting analysis of tail blood samples (Fig. S1). Animal experiments were approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (approval no. IACUC-1910005). All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted. For sample preparation, 100% carbon dioxide was used to euthanize the animals (14).

Experimental mice were raised in the SPF Animal Center of Nanjing Medical University, where the room temperature was maintained at 20-24˚C and ~60% humidity with a 12 h light/dark schedule. A total of 168-week-old male littermates were randomly divided into the VDR^+/+ and VDR^-/- groups (n=8 mice per group). After weaning, the mice were fed a regular diet or a ‘rescue diet’ (Harlan Teklad; Envigo) containing 20% lactose, 1.25% phosphorus and 2% calcium for 8 weeks.

Blood pressure measurements

The ML125 non-invasive blood pressure (NIBP) system (AD Instruments) was used to measure systolic blood pressure in conscious animals. A pneumatic pulse sensor cuff was placed on the tails. After habituation to this setting for 7 days, systolic blood pressure was recorded. To obtain accurate blood pressure recordings, the mice were kept in a motionless and undisturbed state during the measurement. Conditioning was achieved once the mice were processed gently without forcing restraint. Systolic blood pressure was recorded consecutively for 3 days in chambers that were maintained at 31-33˚C. Systolic blood pressure was recorded separately in 10 min intervals over a total of 10 recordings. The average measurement was calculated for the 10 recordings.

VSMC culture

Primary VSMCs were isolated from aortas of 6- to 8-week-old mice. The mice were euthanized using CO₂ (14). After removal of the adventitia, the aorta was opened to expose the endothelial layer under a dissection microscope. Tissues from 6 to 8 animals were pooled and incubated with trypsin (0.25% w/v) at room temperature for 10 min to remove any remaining adventitia and endothelium. Tissues were incubated overnight in α Minimum Essential Medium (αMEM) supplemented with 10% fetal calf serum, 100 U/ml penicillin, 100 µg/ml streptomycin and 0.25 µg/ml amphotericin (complete αMEM) at room temperature before being digested with 425 U/ml collagenase type II (Worthington Biochemical Corporation) for 5 h at room temperature. Isolated VSMCs were expanded in T25 tissue culture flasks in a humidified atmosphere with 5% CO₂ at 37˚C until reaching confluence. VSMCs were identified by negative platelet endothelial cell adhesion molecule1 (marker of endothelial cells) and vimentin (marker of fibroblasts), and positive α-smooth muscle actin (marker of VSMCs) expression. VSMCs from the 3rd to 5th passages were used in the present study (15).

Reverse transcription-quantitative PCR (RT-qPCR)

TRIzol^® reagent (Invitrogen; Thermo Fisher Scientific, Inc.) was used to isolate total RNA from VSMCs according to the manufacturer's instructions. mRNA levels of SOD, Ang II and Ang II type 1 receptor (AT1R) in the VSMCs were detected using RT-qPCR (15). Briefly, first-strand cDNAs were reverse-transcribed from 2 µg of total RNAs using M-MLV (Moloney Murine Leukemia Virus Reverse Transcriptase) with oligo(dT); as the primer) and Rain in 1X M-MLV buffer. Each 1 µl of the cDNA was then applied as a template for the PCR amplification using the SYBR^® Green PCR reagent kit (Toyobo Life Science) in a PCR cycler (Applied Biosystems; Thermo Fisher Scientific, Inc.). GAPDH expression was applied as a loading reference. The target mRNA was amplified in the following thermocycling conditions: initial denaturation for 10 min at 95˚C, 40 cycles of denaturation for 15 sec at 95˚C, annealing for 40 sec at 55˚C, extension for 30 sec at 72˚C and final extension for 7 min at 72˚C. The following PCR primers were used for corresponding gene detection: Ang-II (NC_000023.11) forward primer: 5'-CCTCCCGACTAGATGGACAC-3'and reverse primer: 5'-GAGGGCAGGGGTAAAGAGAG-3'; AT1R (NC_000003.12) forward primer: 5'-ATGTTTCTTGGTGGCTTGGT-3' and reverse primer: 5'-CCTGAGAGGGTCCGAAGAAA-3'; SOD1 (NC_000021.9) forward primer: 5'-AACCATCCACTTCGAGCAGA-3' and reverse primer: 5'-GGTCTCCAACATGCCTCTCT-3'; GAPDH forward primer: 5'-GAACGGGAAGCTCACTGG-3' and reverse primer: 5'-GCCTGCTTCACCACCTTCT-3'. Relative expression level of the respective target gene was calculated according to the 2^-ΔΔCq method (16).

Western blotting

VSMCs were lysed in RIPA buffer (Sigma-Aldrich; Merck KGaA) containing proteinase inhibitors (Sigma-Aldrich). The protein concentration of the lysate was determined using a BCA kit (Merck KGaA). Aliquots (20 µg) of the extracted protein sample were boiled for 5 min, loaded on an 10% SDS-PAGE gel, separated by electrophoresis and then transferred onto a nitrocellulose membrane. The membrane was blocked with 5% milk at room temperature in phosphate-buffered saline/0.05% Tween 20 (PBST) for 3 h and then incubated with a monoclonal antibody against renin (1:1,000; cat. no. 70R-1584; Fitzgerald) overnight at 4˚C. After three washes with PBST, the membrane was incubated with horseradish peroxidase-conjugated secondary antibodies (1:1,000; cat. no. A0208; Beyotime Institute of Biotechnology) at room temperature for 1 h. Finally, the probed bands were visualized using an Enhanced Chemiluminescence reagent (PerkinElmer) and analyzed using ImageJ (version 1; National Institutes of Health) (15). Other used antibodies were as follows: anti-LC3-A (cat. no. AF5225; 1:1,000), anti-Beclin1 (cat. no. AF5123; 1:1,000), anti-AGT7 (cat. no. AA820; 1:1,000), and anti-GAPDH (cat. no. AF0006; 1:1,000) were purchased from Beyotime Institute of Biotechnology.Anti-ATR1 (cat. co. PB0492; 1:1,000), anti-P62 (cat. no. BA2849; 1:1,000), and anti-PRDX4 (cat. co. PB9383; 1:1,000) were purchased from BOSTER Institute of Biotechnology. GAPDH was used as a loading control.

Transmission electron microscopy (TEM)

For cellular TEM observation, VSMCs were cultured for 120 min and then fixed with 2.5% glutaraldehyde and post-fixed with 3% osmium tetroxide for 2 h at room temperature. The specimen was dehydrated in a graded series of ethanol, embedded with EPon812, and stained by uranium acetate and aluminum citratein. Epon resin and then observed with a Hitachi-600 TEM (Hitachi, Ltd.) to evaluate the formation of autophagosomes in the cells (17).

Statistical analysis

All data were statistically analyzed using SPSS software (version 13.0; SPSS, Inc.). In the present study, all data are presented as the mean ± standard deviation. Average data between the groups was compared using the unpaired Student's t-test. The Levene test was applied for distribution analysis. P<0.05 was considered to indicate a statistically significant difference.

Results <sec> <title>Systolic blood pressure is elevated in VDR-/- mice

Systolic blood pressure was measured using the NIBP system in all mice. The systolic blood pressure of the VDR^-/- mice was significantly higher compared with the VDR^+/+ littermate control mice (Fig. 1).

The RAS is upregulated in VDR-/- mice

To understand how VDR deficiency affects hypertension and the RAS, the expression levels of RAS factors Ang II and AT1R were measured using western blotting and RT-qPCR assays in VSMCs isolated from both VDR^-/- and VDR^+/+ mice. Protein expression of AT1R was significantly increased in the VDR^-/- VSMCs compared with the VDR^+/+ VSMCs (Fig. 2A). The mRNA levels of Ang II and AT1R were significantly upregulated in the VDR^-/- VSMCs compared with the VDR^+/+ VSMCs (Fig. 2B). These results suggested that deletion of VDR upregulated the RAS in mice.

Oxidative stress is elevated in VDR-/- mice

The association between hypertension in the VDR^-/- mice and oxidative stress levels were determined in the VSMCs. mRNA levels of SOD were measured using RT-qPCR and protein expression of Prdx4 was measured using western blotting analysis in the VSMCs isolated from both VDR^-/- and VDR^+/+ mice. The results demonstrated that the mRNA levels of SOD were significantly downregulated in the VDR^-/- VSMCs compared with the VDR^+/+ VSMCs (Fig. 3A). The protein expression of Prdx4 was significantly decreased in the VDR^-/- VSMCs compared with the VDR^+/+ VSMCs (Fig. 3B). These data indicated that VDR deficiency upregulated oxidative stress in mice.

Protein expression levels of autophagy-related factors are upregulated in VSMCs of VDR-/- mice

The expression levels of autophagy-related factors, including autophagy-related protein 7 (ATG7), Beclin1, microtubule-associated proteins 1A/1B light chain 3A(LC3A) and nucleoporin p62 (p62), were measured in the VSMCs of VDR^-/- and VDR^+/+ mice using western blotting analysis. ATG7, Beclin1 and LC3Awere significantly upregulated, while p62 was significantly downregulated in the VDR^-/- VSMCs compared with the VRD^+/+ VSMCs (Fig. 4).

TEM reveals increased autophagosomes in VSMCs of VDR-/- mice

Next, the VSMC ultrastructure in the VDR^-/- and VDR^+/+ mice was analyzed using TEM. An increased number of autophagy bodies were observed in the VDR^-/- VSMCs compared with the VDR^+/+ VSMCs (Fig. 5). These results suggested that VDR deficiency could activate autophagy in VSMCs.

Discussion

Oxidative stress can injure blood vessels and serve as a pathogenic factor in hypertension. Numerous studies have demonstrated that there is an imbalance between the anti-oxidative defense system and the production of oxygen free radicals, causing a high level of oxidative stress in patients with hypertension (18-20). Dysfunction of vascular endothelial cells caused by oxidative stress is considered to be the main cause of hypertension (21). Oxidative stress is closely associated with endothelial cell inflammation, hypertrophy, apoptosis, migration, fibrosis and vascular remodeling in hypertension (19,22).

Since the VDR is widely distributed in vascular endothelial cells, VSMCs and cardiomyocytes, the role of VDR in hypertension has received extensive attention. In a previous observational study, activation of the VDR is associated with lower cardiovascular risk and improved survival (23). VDR deficiency can elevate intracellular oxidative stress (23), and VDR agonists have been demonstrated to synergistically alleviate diabetic atherosclerosis by inhibiting oxidative stress (24). Consistent with previous findings, the present study revealed that SOD mRNA levels and Prdx4 protein expression were significantly downregulated in VDR^-/- mice compared with the VDR^+/+ mice. These data suggested that VDR deficiency could increase oxidative stress.

Oxidative stress reflects an imbalance between the reactive oxygen species and a biological ability to detoxify or repair the resulting damage. SOD is an enzyme that downregulates O^2-byscavenging potentially damage-free radical moieties. It acts as a major anti-oxidative enzyme in almost all organisms. Therefore, SOD level reflects the anti-oxidative capacity. The higher the level of SOD, the higher capacity of anti-oxidation, which results the positive balance of anti-oxidation and pro-oxidation. Oppositely, the lower level of the SOD, the lower capacity of anti-oxidation, which causes the negative balance of anti-oxidation and pro-oxidation or oxidative damage (23). The results of the present study revealed that SOD level was decreased in the VDR^-/- mice, which indirectly reflects the upregulated oxidative stress.

Indeed, this pattern is consistent with a number of previous findings. For example, in primary angle closure glaucoma, oxidative stress is increased accompanied with a decrease of SOD level (25). Under normal circumstances, production and clearance of reactive oxygen species (ROS) are in equilibrium. However, once ROS production exceeds clearance, a large number of oxygen free radicals will be generated in the body. In patients with hypertension, increased production of ROS results in decreased levels of SOD, destruction of unsaturated fatty acids and increased lipid peroxidation, causing increased production of malondialdehyde.

Vitamin D signaling plays an important role in the inhibition of renin secretion and synthesis. Disruption of VDR signaling transduction leads to RAS activation, cardiac hypertrophy and hypertension (26). It has been demonstrated that VDR^-/- mice, a model of vitamin D signal disruption, develop hypertension (26). Vitamin D inhibits the renin-angiotensin-aldosterone system by blocking renin gene expression (3). Plasma renin and Ang II levels are negatively correlated with 1,25(OH)₂D₃ (27). Knockout of VDR and cytochrome P450 27B1 in mice results in elevated serum renin and RAS activity and increased blood pressure (5). Xiang et al (28) reported an increase in renin and Ang II mRNA levels in the hearts of 1α(OH)ase and VDR knockout mice. The present study demonstrated that AT1R and Ang II levels increased significantly in VDR^-/- VSMCs, consistent with the previous findings. Vitamin D can inhibit renin gene expression by activating the cAMP response elements at the promoter region of the renin gene (4). Overexpression of VDR can inhibit renin production in renal par acyclic cells (29). Based on the result of the present study and the literature, we hypothesize that VDR deficiency induces overexpression of renin, thus activating the RAS in mouse VSMCs. However, further research is needed to confirm this hypothesis.

Autophagy plays an important role in human health. Numerous disorders are associated with autophagy imbalances, such as hypertension and cardiac disease (30). Vitamin D has been reported to regulate autophagy through multiple pathways, including gene induction, nucleation and elongation of protein maturation and degradation (31). However, the mechanism by which the VDR regulates autophagy has not been fully determined. An improved understanding of this mechanism could be useful for clinical diagnosis and treatment of relative diseases.

To the best of our knowledge, thus far, studies on vitamin D-mediated regulation of autophagy have mainly focus on the phosphatidylinositol 3 kinase/Beclin-1 pathway, Ca²⁺ levels, toll-like receptor signaling pathway, antimicrobial peptides and lysosomes, autophagy related gene expression and inflammatory factors (31). Ang II, a vasoactive peptide, plays a notable role in numerous vascular disorders. An imbalance in vascular autophagy, excessive VSMC proliferation and vascular remodeling can lead to increased vascular resistance and lumen stenosis, resulting in increased blood pressure (32,33). Hypertensive rats demonstrated endothelial dysfunction in aortic and mesenteric arteries, with decreased phosphorylated (p)-Akt, p-mTOR and autophagy marker protein p62, and increased LC3 II/I levels (34). Ang II and glomerular podocyte autophagic activity increased significantly in hypertensive rat kidneys; therefore, high blood pressure caused by kidney injury may be associated with Ang II-induced glomerular podocyte autophagy. Excessive autophagy causes endothelial dysfunction in rats, but it has been revealed that endothelial function can be improved and blood pressure can be reduced through regulating autophagy (35). Ang II induces autophagy through the IAT1R/Rhoda/Rho kinase pathway, causing hypertrophy of VSMCs (36). The interaction between autophagy, oxidative stress and the RAS plays a notable role in vascular remodeling and vascular damage caused by hypertension (37,38).

The objective of the present study was to explore the possible mechanism of VDR deficiency on the RAS and cellular autophagy in a mouse model of vitamin D deficiency. The present study data demonstrated that VDR deficiency increased oxidative stress via downregulating SOD levels and Prdx4 expression, and activating autophagy via upregulation of ATG7, Beclin1 and LC3Aexpression levels in VSMCs. We hypothesize that the increased autophagy level induced by VDR deficiency may be associated with activation of the RAS and signaling pathways downstream of oxidative stress.

In conclusion, the present study suggested that VDR deficiency increased blood pressure by elevating oxidative stress factors and RAS activity, in addition to causing excessive autophagy of VSMCs. The present study offered novel insight into the mechanism by which VDR regulates blood pressure and provided theoretical evidence to guide clinicians on administering 1,25(OH)₂D₃ for the prevention and treatment of hypertension.

Supplementary Material

<italic>VDR KO</italic> mouse verification. Blood samples from <italic>VDRKO</italic> and WT mice were obtained from mice tails. VDR protein expression was detected using western blotting analysis. GAPDH protein expression was used as a control to normalize VDR expression. VDR, vitamin D receptor; KO, knockout/<italic>VDR</italic>-/-; WT, wild-type/<italic>VDR</italic>+/+; NC, negative control.

Acknowledgements

The authors thank Dr Marie Demay (Massachusetts General Hospital, MA, USA) for supplying the VDR^-/- mice for this study.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

YZ performed the research conception and design. XT, JL, YZ and XY performed the experiments. JJ and ZT analyzed and checked the data, and drafted the manuscript. JJ, ZT and XY prepared figures. JJ and YZ edited and revised manuscript. YZ was primarily responsible for final content. JJ and YY confirm the authenticity of all the raw data. All authors read and approved the final manuscript.

Ethics approval and consent to participate

Animal experiments were approved by the Institutional Animal Care and Use Committee of Nanjing Medical University (approval no. IACUC-1910005). All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References 1

Latic

Erben

Vitamin D and cardiovascular disease, with emphasis on hypertension, atherosclerosis, and heart failure

Int J Mol Sci2164832020

32899880

10.3390/ijms21186483

Tamez

Kalim

Thadhani

Does vitamin D modulate blood pressure?

Curr Opin Nephrol Hypertens222042092013

23299053

10.1097/MNH.0b013e32835d919b

Yuan

Pan

Kong

Zheng

Szeto

Wong

Cohen

Klopot

Zhang

1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter

J Biol Chem28229821298302007

17690094

10.1074/jbc.M705495200

Zhou

Cao

Goltzman

Miao

Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice

Kidney Int741701792008

18385669

10.1038/ki.2008.101

Andersen

Przybyl

Haase

von Versen-Höynck

Qadri

Jørgensen

Sorensen

Fruekilde

Poglitsch

Szijarto

Vitamin D depletion aggravates hypertension and target-organ damage

J Am Heart Assoc4e0014172015

25630909

10.1161/JAHA.114.001417

Doumit

Hill

Regulation of adipogenesis and key adipogenic gene expression by 1, 25-dihydroxyvitamin D in 3T3-L1 cells

PLoS One10e01261422015

26030589

10.1371/journal.pone.0126142

Yin

Xia

Luo

Ling

Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism

Eur J Clin Invest42118911962012

22958216

10.1111/j.1365-2362.2012.02706.x

Asano

Watanabe

Ryoden

Usuda

Yamaguchi

Khambu

Takashima

Sato

Sakai

Nagasawa

Uesugi

Vitamin D metabolite, 25-hydroxyvitamin D, regulates lipid metabolism by inducing degradation of SREBP/SCAP

Cell Chem Biol242072172017

28132894

10.1016/j.chembiol.2016.12.017

Wimalawansa

Vitamin D deficiency: Effects on oxidative stress, epigenetics, gene regulation, and aging

Biology (Basel)8302019

31083546

10.3390/biology8020030

Fujii

Ikeda

Kurahashi

Homma

Physiological and pathological views of peroxiredoxin 4

Free Radic Biol Med833733792015

25656995

10.1016/j.freeradbiomed.2015.01.025

Liu

Deng

Chen

Advances in the mechanism of vitamin D affecting autophagy

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue30110311062018

30541655

10.3760/cma.j.issn.2095-4352.2018.011.019

(In Chinese)

Jia

Shen

Mao

Yang

Men

Zhan

Vitamin D receptor genetic polymorphism is significantly associated with decreased risk of hypertension in a Chinese Han population

J Clin Hypertens (Greenwich)166346392014

25196087

10.1111/jch.12386

Pirro

Amling

Delling

Baron

Bronson

Demay

Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia

Proc Natl Acad Sci USA94983198351997

9275211

10.1073/pnas.94.18.9831

Boivin

Hickman

Creamer-Hente

Pritchett-Corning

Bratcher

Review of CO₂ as a euthanasia agent for laboratory rats and mice

J Am Assoc Lab Anim Sci564914992017

28903819

Patel

Bourne

Millán

Arnett

MacRae

Wheeler-Jones

CPD

Orriss

Inhibition of vascular smooth muscle cell calcification by ATP analogues

Purinergic Signal153153262019

31338672

10.1007/s11302-019-09672-3

Livak

Schmittgen

Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method

Methods254024082001

11846609

10.1006/meth.2001.1262

Zhang

Yuan

Wang

Liu

Chen

Germacrone protects against oxygen-glucose deprivation/reperfusion injury by inhibiting autophagy processes in PC12 cells

BMC Complement Med Ther20772020

32145743

10.1186/s12906-020-2865-1

Allison

Hypertension: Oxidative stress and immune activation in hypertension

Nat Rev Nephrol1242016

26639988

10.1038/nrneph.2015.200

Sinha

Dabla

Oxidative stress and antioxidants in hypertension-a current review

Curr Hypertens Rev111321422015

26022210

10.2174/1573402111666150529130922

Guzik

Touyz

Oxidative stress, inflammation, and vascular aging in hypertension

Hypertension706606672017

28784646

10.1161/HYPERTENSIONAHA.117.07802

Wang

Strandgaard

Iversen

Wilcox

Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension

Am J Physiol Regul Integr Comp Physiol296R195R2002009

18685064

10.1152/ajpregu.90506.2008

Irani

Oxidant signaling in vascular cell growth, death, and survival: A review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling

Circ Res871791832000

10926866

10.1161/01.res.87.3.179

Argacha

Egrise

Pochet

Fontaine

Lefort

Libert

Goldman

van de Borne

Berkenboom

Moreno-Reyes

Vitamin D deficiency-induced hypertension is associated with vascular oxidative stress and altered heart gene expression

J Cardiovasc Pharmacol5865712011

21499117

10.1097/FJC.0b013e31821c832f

Farrar

Liu

Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species

Cell Physiol Biochem445325532017

29145191

10.1159/000485089

Shao

Wan

Sun

Cao

Relationship between oxidative stress biomarkers and visual field progression in patients with primary angle closure glaucoma

Oxid Med Cell Longev202027015392020

32831992

10.1155/2020/2701539

Kong

Effect of ANG II type I receptor antagonist and ACE inhibitor on vitamin D receptor-null mice

Am J Physiol Regul Integr Comp Physiol285R255R2612003

12637346

10.1152/ajpregu.00517.2002

Tomaschitz

Pilz

Ritz

Grammer

Drechsler

Boehm

März

Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The ludwigshafen risk and cardiovascular health (LURIC) study

Clin Chim Acta411135413602010

20515678

10.1016/j.cca.2010.05.037

Xiang

Kong

Chen

Cao

Qiao

Zheng

Liu

Gardner

Cardiac hypertrophy in vitamin D receptor knockout mice: Role of the systemic and cardiac renin-angiotensin systems

Am J Physiol Endocrinol Metab288E125E1322005

15367398

10.1152/ajpendo.00224.2004

Kong

Qiao

Zhang

Liu

Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium

Kidney Int74157715812008

19034301

10.1038/ki.2008.452

Galluzzi

Green

Autophagy-independent functions of the autophagy machinery

Cell177168216992019

31199916

10.1016/j.cell.2019.05.026

Tai

Peng

Zhou

Zheng

The roles of autophagy in vascular smooth muscle cells

Int J Cardiol211162016

26954728

10.1016/j.ijcard.2016.02.128

Salabei

Hill

Implications of autophagy for vascular smooth muscle cell function and plasticity

Free Radic Biol Med656937032013

23938401

10.1016/j.freeradbiomed.2013.08.003

Justin Rucker

Crowley

The role of macrophages in hypertension and its complications

Pflugers Arch4694194302017

28251313

10.1007/s00424-017-1950-x

Dong

Xing

Liu

Wang

Liang

Zhou

Yang

Zhang

Gao

Tetrahydroxystilbene glucoside inhibits excessive autophagy and improves microvascular endothelial dysfunction in prehypertensive spontaneously hypertensive rats

Am J Chin Med44139314122016

27776426

10.1142/S0192415X16500786

Dong

Xing

Liang

Tian

Gao

Wang

Zhang

Tetrahydroxystilbene glycoside improves microvascular endothelial dysfunction and ameliorates obesity-associated hypertension in obese ZDF rats via inhibition of endothelial autophagy

Cell Physiol Biochem432933072017

28854420

10.1159/000480410

Mondaca-Ruff

Riquelme

Quiroga

Norambuena-Soto

Sanhueza-Olivares

Villar-Fincheira

Hernández-Díaz

Cancino-Arenas

San Martin

García

Angiotensin II-regulated autophagy is required for vascular smooth muscle cell hypertrophy

Front Pharmacol915532018

30804791

10.3389/fphar.2018.01553

Wang

Rothermel

Hill

Autophagy in hypertensive heart disease

J Biol Chem285850985142010

20118246

10.1074/jbc.R109.025023

Zhou

Han

The role of autophagy in angiotensin II-induced pathological cardiac hypertrophy

J Mol Endocrinol57R143R1522016

27620875

10.1530/JME-16-0086

Figure 1

Systolic blood pressure of the VDR^-/- and VDR^+/+ mice. Average systolic blood pressure was calculated from 10 measurements using the NIBP non-invasive blood pressure system in the KO and WT mice. BP, blood pressure; KO, knockout/VDR^-/-; WT, wild-type/VDR^+/+; VDR, vitamin D receptor.

Figure 2

Ang II and AT1R expression levels in VSMCs of VDRKO mice. (A) Protein expression levels of AT1R in the VSMCs isolated from VDRKO and VDRWT mice were detected using western blotting analysis and quantified. (B) mRNA levels of Ang II and AT1R in the VSMCs isolated from KO and WT mice were analyzed using reverse transcription-quantitative PCR. The data are presented as an average from three independent assays. WT levels were set at 1.0 for data normalization. KO, knockout/VDR^-/-; WT, wild-type/VDR^+/+; Ang, angiotensin; AT1R, Ang II type 1 receptor; VSMCs, vascular smooth muscle cells; VDR, vitamin D receptor.

Figure 3

Expression levels of SOD and Prdx4 in VSMCs of VDR^-/- mice. (A) mRNA levels of SOD in the VSMCs isolated from the VDRKO and VDRWT mice were analyzed using reverse transcription-quantitative PCR. The average intensity of the corresponding mRNA levels of the genes was calculated from three independent assays. (B) Protein expression of Prdx4 in the samples at the same conditions as A was detected using western blotting analysis. The average data are from three independent assays. WT levels were set at 1.0 for data normalization. SOD, superoxide dismutase; Prdx4, peroxiredoxin4; KO, knockout/VDR^-/-; WT, wild-type/VDR^+/+; VSMCs, vascular smooth muscle cells; VDR, vitamin D receptor.

Figure 4

Protein expression of ATG7, Beclin1, LC3A and p62 in VSMCs. Protein expression of ATG7, Beclin1, LC3A and p62 in VSMCs isolated from VDRKO and VDRWT mice was detected using western blotting analysis. (A) Representative images of the corresponding western blot images. The average intensities of (B) ATG7, (C) p62, (D) Beclin1 and (E) LC3A are summarized in the corresponding bar graphs from three independent assays. WT levels were set at 1.0 for data normalization. KO, knockout/VDR^-/-; WT, wild-type/VDR^+/+; VSMCs, vascular smooth muscle cells; ATG7, autophagy-related protein 7; p62, nucleoporin p62; LC3A, microtubule-associated proteins 1A/1B light chain 3A; VDR, vitamin D receptor.

Figure 5

Ultrastructural alterations in VSMCs of VDR^-/- mice. Changes in VSMC ultrastructure in the (A) VDRWT and (B) VDRKO mice were examined using TEM (scale bar, 500 nm). Autophagy bodies are indicated by the red arrows. PM, plasma membrane; VDR, vitamin D receptor; VSMCs, vascular smooth muscle cells; KO, knockout/VDR^-/-; WT, wild-type/VDR^+/+.